文献速递脑血管病

抑制PAI-1改善老年高血压大鼠急性缺血性卒中后的脑侧支灌注与损伤

Inhibition of PAI (Plasminogen Activator Inhibitor)-1 Improves Brain Collateral Perfusion and Injury After Acute Ischemic Stroke in Aged Hypertensive Rats.
PubMed 文献 · Stroke · 2018-01-01

研究在老年(约50周)和年轻(约18周)自发性高血压大鼠中,采用大脑中动脉闭塞2小时再灌注2小时模型,观察PAI-1抑制剂TM5441的作用。老年大鼠脑损伤更重(41±2% vs 23±2%,P<0.05),TM5441改善脑损伤但不影响出血,并使侧支灌注增加38±7%、软脑膜吻合小动脉扩张44±10%,该效应被一氧化氮合酶抑制所消除。

要点

  • 老年自发性高血压大鼠脑损伤较年轻大鼠更重(41±2% vs 23±2%,P<0.05)。
  • PAI-1抑制剂TM5441改善两组脑损伤,但不影响出血。
  • TM5441使侧支灌注增加38±7%、软脑膜吻合小动脉扩张44±10%。

核心结论

  • 老年自发性高血压大鼠损伤增加似乎与侧支灌注不良、出血性转化、淀粉样β-42增加和氧化应激有关。
  • 抑制PAI-1减少两组自发性高血压大鼠的梗死,可能部分由于侧支灌注增加。

研究设计与样本

  • 老年(约50周)和年轻(约18周)自发性高血压大鼠接受大脑中动脉闭塞2小时再灌注2小时,分别给予或不给予PAI-1抑制剂TM5441。

主要发现

  • 大脑中动脉闭塞期间脑血流变化组间相似,两组侧支灌注均不良且再灌注不完全。
  • 老年自发性高血压大鼠脑损伤较年轻大鼠更重(41±2% vs 23±2%,P<0.05),且脑内淀粉样β-42沉积和循环oxLDL增加。
  • 50%老年自发性高血压大鼠损伤脑内可见红细胞聚集和出血,年轻大鼠未见;该亚组老年大鼠循环PAI-1升高(16±3 vs 6±2 ng/mL,P<0.05)。
  • TM5441改善脑损伤但不影响出血;TM5441使侧支灌注增加38±7%、软脑膜吻合小动脉扩张44±10%,该效应被一氧化氮合酶抑制所消除。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Aging and hypertension, comorbidities prevalent in the stroke population, are associated with poor collateral status and worsened stroke outcome. However, underlying mechanisms by which these conditions affect stroke outcome are not clear. We studied the role of PAI (plasminogen activator inhibitor)-1 that is increased in aging and hypertension on brain and vascular expression of inflammatory factors and perfusion that may contribute to worse stroke outcomes. Methods- Aged (≈50 weeks) and young (≈18 weeks) spontaneously hypertensive rats (SHR) were subjected to ischemia by middle cerebral artery occlusion (2 hours) and reperfusion (2 hours) with or without treatment with the PAI-1 inhibitor TM5441. Changes in middle cerebral artery and collateral perfusion territories were measured by multisite laser Doppler. Reactivity to TM5441 was studied using isolated and pressurized leptomeningeal anastomotic arterioles. Brain injury was determined by 2,3,5-triphenyltetrazolium staining and quantitative immunohistochemistry of amyloid-β-42, PAI-1, and hemoglobin. Circulating inflammatory factors were measured by ELISA. Results- Changes in cerebral blood flow during middle cerebral artery occlusion were similar between groups, with both having poor collateral perfusion and incomplete reperfusion. However, aged SHR had greater brain injury versus young (41±2 versus 23±2%, P<0.05) as well as increased brain deposition of amyloid-β-42 and circulating oxLDL (oxidized low-density lipoprotein). Erythrocyte aggregation and hemorrhage within the injured brain was observed in 50% of aged but no young SHR, with increased circulating PAI-1 in this subgroup of aged SHR (16±3 versus 6±2 ng/mL, P<0.05). PAI-1 inhibition with TM5441 improved brain injury but did not affect hemorrhage. TM5441 increased collateral perfusion by 38±7% and dilated leptomeningeal anastomotic arterioles by 44±10%, which was abolished by nitric oxide synthase inhibition. Conclusions- Increased injury in aged SHR seemed to be related to poor collateral perfusion, hemorrhagic transformation, increased amyloid-β-42, and oxidative stress. PAI-1 inhibition reduced infarction in both groups of SHR that possibly due, in part, to increased collateral perfusion.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chan SL, Bishop N, Li Z, et al. Inhibition of PAI (Plasminogen Activator Inhibitor)-1 Improves Brain Collateral Perfusion and Injury After Acute Ischemic Stroke in Aged Hypertensive Rats. Stroke. 2018. PMID: 29991657. doi:10.1161/STROKEAHA.118.022056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。